Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $1.79B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ELTX | ELICIO THERAPEUTICS INC | $189.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.22B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MGNX | MACROGENICS INC | $186.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.58B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BLZE | BACKBLAZE INC | $241.19M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| XNCR | XENCOR INC | $852.20M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PCOR | PROCORE TECHNOLOGIES INC | $8.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ASST | STRIVE INC | $996.58M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| PHAR | PHARMING GROUP NV | $1.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXOD | EXODUS MOVEMENT INC | $210.77M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AGBK | AGI INC | $1.36B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TRVI | TREVI THERAPEUTICS INC | $1.77B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CABA | CABALETTA BIO INC | $309.48M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| WALD | WALDENCAST PLC | $97.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AGMB | AGOMAB THERAPEUTICS NV | $523.43M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IRON | DISC MEDICINE INC | $2.52B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.88B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DMRA | DAMORA THERAPEUTICS INC | $1.44B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TLX | TELIX PHARMACEUTICALS LTD | $3.53B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.32B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $147.23M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ERAS | ERASCA INC | $2.83B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MGPI | MGP INGREDIENTS INC | $409.47M | 2.51% | -4.30% | $0.1200 | $0.48 | 54% | 1 | ||
| CPS | COOPER-STANDARD HOLDINGS INC | $511.47M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BLSH | BULLISH | $5.51B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DC | DAKOTA GOLD CORP | $707.64M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BIOA | BIOAGE LABS INC | $748.24M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $207.94M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARVN | ARVINAS INC | $628.10M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PEPG | PEPGEN INC | $107.13M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DEFT | DEFI TECHNOLOGIES INC | $290.91M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $2.10B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RLMD | RELMADA THERAPEUTICS INC | $773.04M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PERI | PERION NETWORK LTD | $400.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IPX | IPERIONX LTD | $977.02M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KWR | QUAKER CHEMICAL CORP | $2.31B | 1.51% | -1,418.60% | $0.5080 | $2.01 | 35% | 0 | 2026-04-30 | |
| CNTX | CONTEXT THERAPEUTICS INC | $215.00M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ABVX | ABIVAX SA | $8.34B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BILL | BILL HOLDINGS INC | $3.69B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TYRA | TYRA BIOSCIENCES INC | $1.82B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ELAN | ELANCO ANIMAL HEALTH INC | $10.84B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| WPM | WHEATON PRECIOUS METALS CORP | $56.70B | 0.16% | 26.50% | $0.1950 | $0.20 | 2% | 0 | ||
| DCGO | DOCGO INC | $69.82M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MARA | MARA HOLDINGS INC | $4.08B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CLFD | CLEARFIELD INC | $381.96M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NKTX | NKARTA INC | $191.77M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LTM | LATAM AIRLINES GROUP SA | $26.94B | N/A | 48.50% | N/A | N/A | N/A | N/A | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $207.69M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MMED | MINIMED GROUP INC | $3.38B | N/A | N/A | N/A | N/A | N/A | N/A | ||
| LBRX | LB PHARMACEUTICALS INC | $877.16M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRRO | KORRO BIO INC | $181.87M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SLDB | SOLID BIOSCIENCES INC | $693.66M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PCVX | VAXCYTE INC | $8.25B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CGEM | CULLINAN THERAPEUTICS INC | $777.76M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CGTX | COGNITION THERAPEUTICS INC | $105.44M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CRVO | CERVOMED INC | $33.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $447.76M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $449.76M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.65B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.